When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Even still, Ramaswamy and Musk are set to be equipped with power to radically change the federal government apparatus, or ...

South Dakota Republican Mike Rounds called Wray a “very good man” and had no issues with how Wray led the FBI. Other ...

The Federal Trade Commission requires influencers to disclose when a post is a paid advertisement — and a public interest ...

Biden’s sweeping pardon of his son, HUNTER BIDEN, is poised to further embolden President-elect DONALD TRUMP, who has vowed ...

Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...

Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss market continues to expand and Novo Nordisk is ...

From Novo Nordisk's haemophilia portfolio, there are two oral presentations of note: first on the efficacy and safety results ...

Yet at the annual meeting of the Menopause Society earlier this fall, researchers presented new evidence that hormone therapy ...

Clinical data include analyses of novel, investigational therapies with the potential to help address unmet needs in sickle cell disease and hemophiliaNew data from the HIBISCUS phase 2 trial ...